BioAge Labs, Inc. (BIOA)
6.35
+0.14
(+2.25%)
USD |
NASDAQ |
Oct 09, 16:00
6.35
0.00 (0.00%)
After-Hours: 20:00
BioAge Labs Total Liabilities (Quarterly) : 22.02M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 22.02M |
| March 31, 2026 | 18.53M |
| December 31, 2025 | 23.48M |
| September 30, 2025 | 27.63M |
| June 30, 2025 | 27.37M |
| March 31, 2025 | 30.67M |
| Date | Value |
|---|---|
| December 31, 2024 | 35.17M |
| September 30, 2024 | 23.63M |
| June 30, 2024 | 18.70M |
| March 31, 2024 | 22.28M |
| December 31, 2023 | 66.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Neumora Therapeutics, Inc. | 80.73M |
| Alumis, Inc. | 108.46M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 396.93M |
| Shareholders Equity (Quarterly) | 374.91M |
| Debt to Equity Ratio | 0.0076 |
| Current Ratio | 17.19 |
| Net Debt Paydown Yield | 0.13% |